APOE and Alzheimer disease: These findings suggest that targeting the interaction between ApoE and Aβ may offer therapeutic intervention opportunities at early disease stages, emphasizing the importance of understanding the differential effects of ApoE isoforms on AD pathogenesis (Figure 6) [146].